| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0032 | 0.9 |